Back to top
more

Tenet Healthcare (THC)

(Delayed Data from NYSE)

$115.95 USD

115.95
3,242,552

+3.66 (3.26%)

Updated May 1, 2024 04:00 PM ET

After-Market: $115.95 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (174 out of 251)

Industry: Medical - Hospital

Better trading starts here.

Zacks News

Tenet Healthcare (THC) Falls More Steeply Than Broader Market: What Investors Need to Know

Tenet Healthcare (THC) concluded the recent trading session at $89.22, signifying a -1.12% move from its prior day's close.

Brookdale Senior's (BKD) Q4 Loss Widens, Shares Drop 13%

Brookdale Senior's (BKD) Q4 results were hit by inflationary challenges, an increase in facility operating lease expense and higher income tax provision. It expects adjusted EBITDA within $90-$95 million in first-quarter 2024.

Teladoc Health (TDOC) Q4 Loss Narrows on Lower Expenses

Teladoc Health's (TDOC) Q4 results were aided by strong contributions from the Integrated Care unit and a decline in restructuring costs. Management targets adjusted EBITDA at a minimum of $425 million in 2025.

Tenet Healthcare (THC) Q4 Earnings Beat on Hospital Operations

Tenet Healthcare (THC) expects net operating revenues to be between $19.9 billion and $20.3 billion in 2024.

Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Can Tenet's (THC) Q4 Earnings Beat on Rising Patient Admissions?

Tenet's (THC) fourth-quarter results are likely to reflect higher Ambulatory Care operating revenues and supply costs.

Gear Up for Tenet (THC) Q4 Earnings: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Strength Seen in Tenet (THC): Can Its 7.7% Jump Turn into More Strength?

Tenet (THC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Tenet Healthcare (THC) Expected to Beat Earnings Estimates: Should You Buy?

Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

HCA Healthcare (HCA) Beats Q4 Earnings and Revenue Estimates

HCA (HCA) delivered earnings and revenue surprises of 16.83% and 4.52%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Tenet Healthcare (THC) Outpaced the Stock Market Today

Tenet Healthcare (THC) closed the most recent trading day at $83.57, moving +0.82% from the previous trading session.

Will Tenet (THC) Beat Estimates Again in Its Next Earnings Report?

Tenet (THC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know

In the most recent trading session, Tenet Healthcare (THC) closed at $81.40, indicating a -0.94% shift from the previous trading day.

Tenet Healthcare (THC) Rises As Market Takes a Dip: Key Facts

In the latest trading session, Tenet Healthcare (THC) closed at $79.36, marking a +0.04% move from the previous day.

Tenet Healthcare (THC) Gains 60% in a Year: More Room to Run?

Diversified treatment network, solid patient volumes in the Hospital segment and robust cash flows continue to drive Tenet Healthcare (THC).

Tenet Healthcare (THC) Outperforms Broader Market: What You Need to Know

Tenet Healthcare (THC) closed at $75.56 in the latest trading session, marking a +0.77% move from the prior day.

Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems

HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems are part of the Zacks Industry Outlook article.

Kaibalya Pravo Dey headshot

5 Hospital Stocks to Watch Amid Promising Industry Trends

Rising patient volumes and technological advancements for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving operating efficiency.

Why Is Tenet (THC) Up 23.8% Since Last Earnings Report?

Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Tenet (THC) to Divest 3 Hospitals to Novant to Reduce Debt

Tenet (THC) expects the divestment of the three South Carolina hospitals to fetch around $2.4 billion in cash.

Tenet Healthcare (THC) Q3 Earnings Beat on Solid Ambulatory Care

Tenet Healthcare's (THC) Q3 results gain on improved adjusted admissions and higher pricing yield. Management expects adjusted EPS of $5.43-$6.05 for 2023.

Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Tenet Healthcare (THC) Surpasses Q3 Earnings and Revenue Estimates

Tenet (THC) delivered earnings and revenue surprises of 20% and 1%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.